Medicine & TechnologyThe Denver Museum of Nature & Science special exhibits gallery explodes with maze experiences that propel you down paths of mystifying illusions and brain teasing puzzles in the "Mazes & Brain Games" experience, which opens May 20.
A new study on brain activities reveals that this particular area is responsible for evaluating decisions we make. Learn more about 'performance monitoring' and the functions of the medial frontal cortex.
Researchers saw little but distinct changes in the brain of astronauts who were deployed to long-term space missions. Learn more about the phenomenon and how it impacts the health of astronauts.
A revolutionary brain implant can reverse the symptoms of incurable Parkinson's disease. Read this article to know how it works and improves the life quality of the patients.
Experts revived the long-forgotten post-stroke solution that calms overexcited neurons. Read more about how this type of excitotoxicity works in patients who experienced a stroke.
Northwestern Medicine carried out an investigation over neurological diseases that target the brain's language functions. Read on to know what the experts found about between the language-related impairment and the brain diseases that initiate it.
Young viewers are getting hooked on viewing short videos on Tiktok that experts compare to making kids live in a candy store. Find out what experts say about this.
As a COVID-19 effect, a person’s brain may be damaged, after even the mildest forms of infection. Learn more about the so-called ‘brain fog’ after infection.
The development of mathematical skills in children relies on number sense in early childhood. Find out which brain circuit to target to boost math abilities.
HMNC Brain Health ("HMNC'' or the "Company"), a global clinical stage biopharmaceutical company pioneering the development of personalized therapies in psychiatry, together with Develco Pharma, a company specializing in the development and manufacture of orally administered modified, prolonged & chrono release drugs today announced promising top-line results from the Phase 2 Proof-of-Concept investigator-initiated trial of its oral prolonged-release formulation of ketamine (KET01) in Treatment-Resistant Depression (TRD).
Research reveals the link between dementia and acute kidney injury. Discover how patients hospitalized for AKI are more likely to develop the condition.
A new study shows people with autism are thinking in the same way non-autistic people think. Find out how researchers were able to identify that similarity.
Brain implants might be the future for the patients of neurological disease and paralysis. Read about this new innovation that was found effective at assisting ALS patients who use communication devices.